These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20157341)

  • 1. Synthesis of Biotinylated Tumor-Associated Carbohydrate Antigens for Immunological Studies.
    Zhu J; Wan Q; Danishefsky SJ
    Tetrahedron Lett; 2009 Feb; 50(6):712-714. PubMed ID: 20157341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Synthesis and Biological Characterization of Acetal-Free Mimics of the Tumor-Associated Carbohydrate Antigens.
    Sadraei SI; Reynolds MR; Trant JF
    Adv Carbohydr Chem Biochem; 2017; 74():137-237. PubMed ID: 29173726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual lactam formation occurring in the synthesis of a biotinylated T-antigen-serine derivative.
    Bay S; Berthier-Vergnes O; Biberovic V; Cantacuzène D
    Carbohydr Res; 1997 Aug; 303(1):25-31. PubMed ID: 9345750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate antigens: synthesis aspects and immunological applications in cancer.
    Freire T; Bay S; Vichier-Guerre S; Lo-Man R; Leclerc C
    Mini Rev Med Chem; 2006 Dec; 6(12):1357-73. PubMed ID: 17168812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
    Huang J; Byrd JC; Yoon WH; Kim YS
    Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis of biotinylated carbohydrates as probes for carbohydrate-recognizing proteins.
    Angus DI; Kiefel MJ; von Itzstein M
    Bioorg Med Chem; 2000 Dec; 8(12):2709-18. PubMed ID: 11131162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate vaccines as immunotherapy for cancer.
    Slovin SF; Keding SJ; Ragupathi G
    Immunol Cell Biol; 2005 Aug; 83(4):418-28. PubMed ID: 16033538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate antigens as targets for active specific immunotherapy.
    Ragupathi G
    Cancer Immunol Immunother; 1996 Nov; 43(3):152-7. PubMed ID: 9001568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coupling carbohydrates to proteins for glycoconjugate vaccine development using a pentenoyl group as a convenient linker.
    Wang Q; Guo Z
    Methods Mol Biol; 2011; 751():309-16. PubMed ID: 21674339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses of biotinylated alpha-galactosylceramides and their effects on the immune system and CD1 molecules.
    Sakai T; Naidenko OV; Iijima H; Kronenberg M; Koezuka Y
    J Med Chem; 1999 May; 42(10):1836-41. PubMed ID: 10346936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative immunological studies of tumor-associated Lewis X, Lewis Y, and KH-1 antigens.
    Guo J; Jiang W; Li Q; Jaiswal M; Guo Z
    Carbohydr Res; 2020 Jun; 492():107999. PubMed ID: 32272238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmenting the immunogenicity of carbohydrate tumor antigens.
    Livingston PO
    Semin Cancer Biol; 1995 Dec; 6(6):357-66. PubMed ID: 8938274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated carbohydrate antigens for clinical diagnostic markers--its effectiveness and limitations.
    Inagaki Y; Song P; Tang W; Kokudo N
    Drug Discov Ther; 2015 Apr; 9(2):129-32. PubMed ID: 25994064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gangliosides as carbohydrate antigens associated with cancer and their possible use in tumor immunotherapy].
    Horwacik I
    Przegl Lek; 2004; 61 Suppl 2():14-9. PubMed ID: 15686040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen.
    Buskas T; Ingale S; Boons GJ
    Angew Chem Int Ed Engl; 2005 Sep; 44(37):5985-8. PubMed ID: 16108081
    [No Abstract]   [Full Text] [Related]  

  • 16. Total syntheses of tumor-related antigens N3: probing the feasibility limits of the glycal assembly method.
    Kim HM; Kim IJ; Danishefsky SJ
    J Am Chem Soc; 2001 Jan; 123(1):35-48. PubMed ID: 11273599
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.